JOINN will attend the 7th ADC & Novel Antibody Drug Development Summit
2026-03-26
The 7th ADC & Novel Antibody Drug Development Summit will grandly open at the Shanghai Marriott Hotel Pudong on April 1–2, 2026.The summit will bring together decision-makers and thought leaders from MNCs, investment institutions, clinical practice, biotech companies, and research institutes. It will focus on the entire industrial chain of R&D, manufacturing, and application of ADCs and novel antibody drugs, covering four core sectors: pharmaceutical R&D, clinical medicine, industrial manufacturing, and capital investment.As spring blooms with warm weather, it is the perfect time to gather. We look forward to meeting you in Shanghai on April 1–2, 2026!
Zhao Yanfang, Project Leader of the In Vitro Biology Department, Drug Discovery Division at Beijing Joinn Laboratories Co., Ltd., will attend the summit and deliver a keynote speech entitled Establishment of In Vitro Biological Evaluation Systems for ADC Drugs and Application of Key Technologies.In addition, Joinn Laboratories will set up a booth (Booth #A5) to showcase its comprehensive solutions covering the full drug life cycle. Industry colleagues are warmly welcome to visit for in-depth exchanges and discussions.
